Technical Analysis for SURF - Surface Oncology, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Down |
Historical SURF trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New Downtrend | Bearish | 6.37% | |
Lower Bollinger Band Walk | Weakness | 6.37% | |
Wide Bands | Range Expansion | 6.37% | |
Oversold Stochastic | Weakness | 6.37% | |
180 Bearish Setup | Bearish Swing Setup | 6.87% | |
Lower Bollinger Band Walk | Weakness | 6.87% | |
Wide Bands | Range Expansion | 6.87% | |
Lower Bollinger Band Touch | Weakness | 6.87% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
60 Minute Opening Range Breakout | about 6 hours ago | |
Rose Above Previous Day's High | about 11 hours ago | |
Up 5% | about 11 hours ago | |
Up 3% | about 11 hours ago | |
Up 2% | about 11 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
Surface Oncology is a clinical-stage immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment with lead programs targeting CD47 and CD73. Surface’s novel cancer immunotherapies are designed to achieve a clinically meaningful and sustained anti-tumor response, alone or in combination with other therapies. The company has a pipeline of immunotherapies and a strategic collaboration with Novartis focused on up to three next-generation cancer immunotherapies.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunotherapy Cancer Treatments Cancer Immunotherapy Virotherapy Tumor Immunotherapies Cancer Research Novel Cancer Cd73 CD47 Active Immunotherapy Tumor Microenvironment
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunotherapy Cancer Treatments Cancer Immunotherapy Virotherapy Tumor Immunotherapies Cancer Research Novel Cancer Cd73 CD47 Active Immunotherapy Tumor Microenvironment
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 14.38 |
52 Week Low | 1.38 |
Average Volume | 1,603,268 |
200-Day Moving Average | 7.61 |
50-Day Moving Average | 10.57 |
20-Day Moving Average | 10.35 |
10-Day Moving Average | 9.34 |
Average True Range | 0.85 |
ADX | 26.09 |
+DI | 15.73 |
-DI | 31.19 |
Chandelier Exit (Long, 3 ATRs ) | 10.15 |
Chandelier Exit (Short, 3 ATRs ) | 10.56 |
Upper Bollinger Band | 12.79 |
Lower Bollinger Band | 7.92 |
Percent B (%b) | 0.23 |
BandWidth | 46.98 |
MACD Line | -0.63 |
MACD Signal Line | -0.37 |
MACD Histogram | -0.2613 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 9.83 | ||||
Resistance 3 (R3) | 9.78 | 9.46 | 9.70 | ||
Resistance 2 (R2) | 9.46 | 9.25 | 9.49 | 9.65 | |
Resistance 1 (R1) | 9.24 | 9.13 | 9.35 | 9.29 | 9.60 |
Pivot Point | 8.92 | 8.92 | 8.98 | 8.95 | 8.92 |
Support 1 (S1) | 8.70 | 8.71 | 8.81 | 8.75 | 8.44 |
Support 2 (S2) | 8.38 | 8.59 | 8.41 | 8.39 | |
Support 3 (S3) | 8.16 | 8.38 | 8.35 | ||
Support 4 (S4) | 8.21 |